eFFECTOR Therapeutics, Inc.

( )
EFTR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Finance » Financial Conglomerates
LCIDLucid Group, Inc. 2.09%40.030.0%$1605.53m
CCitigroup, Inc. -1.59%64.261.0%$1443.31m
DWACDigital World Acquisition Corp. -10.27%77.450.0%$526.82m
AXPAmerican Express Co. -2.85%161.431.8%$519.71m
RIOTRiot Blockchain, Inc. -6.47%17.490.0%$164.89m
DOCNDigitalOcean Holdings, Inc. -1.50%56.520.0%$129.95m
EQHEquitable Holdings, Inc. -1.88%34.400.0%$83.71m
JXNJackson Financial, Inc. (Michigan) -0.45%42.460.0%$47.80m
IONQIonQ, Inc. -3.28%11.800.0%$39.59m
CFVICF Acquisition Corp. VI -2.17%12.620.0%$38.82m
PLPlanet Labs PBC 3.50%6.500.0%$30.66m
GGPIGores Guggenheim, Inc. -1.25%11.040.0%$30.64m
EXPIeXp World Holdings, Inc. -2.18%26.490.0%$22.80m
SLDPSolid Power, Inc. -8.62%7.740.0%$19.44m
FBCFlagstar Bancorp, Inc. -2.99%49.731.4%$18.51m

Company Profile

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in San Diego, CA.